LF IV contains S-enantiomer of levofloxacin .It belongs to fluoroquinolone antibiotic, which acts by inhibiting DNA gyrase thus initiates DNA breakage and thus prevent the bacterial infection. Its bioavailability is about 99%. It is indicated in Community acquired pneumonia, Complicated and Uncomplicated urinary tract infection, Nosocomial infections and Chronic bronchitis.
ANTI-BIOTICS / ANTI-BACTERIAL
Levofloxacin 500 mg. per 100 ml. IV